Disease-modifying anti-inflammatory drugs (DMAIDs): shaping the future of inflammatory bowel disease - Top-Institutions - MDSpire

Disease-modifying anti-inflammatory drugs (DMAIDs): shaping the future of inflammatory bowel disease

  • By

  • Sailish Honap

  • Laurent Peyrin-Biroulet

  • February 8, 2025

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Clinical Research

  • #2

    Mount Sinai Health System
    Mount Sinai Health System

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Translational Medicine

  • #3

    Cedars-Sinai Medical Center
    Cedars-Sinai Medical Center

    Los Angeles, CA

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Clinical Trials

  • #4

    University of Chicago Medicine
    University of Chicago Medicine

    Chicago, IL

    Key Differentiators

    • Gastroenterology
    • Inflammatory Bowel Disease
    • Epidemiology

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Gastroenterology
    • Immunology
    • Clinical Research

Original Source(s)

Disease-modifying anti-inflammatory drugs (DMAIDs): shaping the future of inflammatory bowel disease

  • by Sailish Honap, Laurent Peyrin-Biroulet

  • February 8, 2025

Related Content

Gut microbial bile salt hydrolase as a metabolic gatekeeper in digestive homeostasis and disease

The role of the complement system in gastrointestinal-related diseases

Nurr1 deficiency orchestrates a coupled liver–gut pathological axis revealed by multi-omics and deep-learning histopathology